|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Hypertension, ocular |
|
Glaucoma, open- angle |
|
Hypertension, essential |
| |
|
|
SIDE EFFECTS:
|
|
agranulocytosis |
|
alopecia |
|
arthralgia |
|
asthenia |
|
AV block |
|
diabetes mellitus |
|
diarrhea |
|
dizziness |
|
dyspepsia |
|
dyspnea |
|
epiphora |
|
exfoliative dermatitis |
|
fatigue |
|
headache |
|
heart failure |
|
hyperglycemia |
|
hypertriglyceridemia |
|
hypoglycemia |
|
hypotension |
|
impotence |
|
insomnia |
|
musculoskeletal pain |
|
nausea/vomiting |
|
ocular irritation |
|
pharyngitis |
|
pruritus |
|
sinus bradycardia |
|
skin hyperpigmentation |
|
wheezing |
|
xerosis |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
vasospastic angina |
|
asthma |
|
breast-feeding |
|
bronchitis |
|
children |
|
chronic obstructive pulmonary disease (COPD) |
|
contact lenses |
|
depression |
|
diabetes mellitus |
|
driving or operating machinery |
|
elderly |
|
emphysema |
|
heart failure |
|
hyperthyroidism |
|
myasthenia gravis |
|
peripheral vascular disease |
|
pheochromocytoma |
|
pregnancy |
|
psoriasis |
|
pulmonary disease |
|
Raynaud's disease |
|
renal disease |
|
renal failure |
|
renal impairment |
|
surgery |
|
thyroid disease |
|
thyrotoxicosis |
|
|
ADULT DOSE:
|
|
Antihypertensive-Oral, 10 mg once a day initially, the dosage being doubled, if necessary, after seven to fourteen days .
Note: Geriatric patients may have increased or decreased sensitivity to the effects of the usual adult dose. An initial dose of 5 mg should be considered for elderly patients .
For patients with renal function impairment who are undergoing hemodialysis, an initial dose of 5 mg once a day is recommended, increased by 5 mg a day every fourteen days, as necessary, up to a maximum daily dose of 20 mg . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Dosage has not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|